<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Cell Therapeutics, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, no par value per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
150934107
- --------------------------------------------------------------------------------
(CUSIP Number)
Will Horne c/o Phoenix Partners, 1000 Second Avenue, Suite 3600, Seattle, WA
98104
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
December 23, 1999
-------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [_].
NOTE: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 19
<PAGE>
SCHEDULE 13D
- ------------------------------------------------------------------------------
CUSIP NO. 150934107 PAGE 2 OF 19 PAGES
- ------------------------------------------------------------------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 THE PHOENIX PARTNERS III
LIQUIDATING TRUST
SEE ITEM 2 FOR IDENTIFICATION OF TRUSTEE.
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [X]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
WC
- ------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM
S 2(d) OR 2(e)[_]
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
WASHINGTON
- ------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF 200,677(A)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
0(A)
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING 200,677(A)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
0(A)
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
200,677(A)
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
12 (SEE INSTRUCTIONS)
[X]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
1.29%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
14
00
- ------------------------------------------------------------------------------
(A) Excludes an aggregate of 486,282 shares owned beneficially by the other
reporting persons indicated in this Schedule 13D, as to which this reporting
person disclaims beneficial ownership. See Exhibit A hereto.
---------
<PAGE>
SCHEDULE 13D
- ------------------------------------------------------------------------------
CUSIP NO. 150934107 PAGE 3 OF 19 PAGES
- ------------------------------------------------------------------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 STUART C. JOHNSTON
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [X]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
WC
- ------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM
S 2(d) OR 2(e)[_]
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
UNITED STATES
- ------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF 200,677(A)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
0(A)
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING 200,677(A)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
0(A)
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
200,677(A)
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
12 (SEE INSTRUCTIONS)
[X]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
1.29%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
14
IN
- ------------------------------------------------------------------------------
(A) Excludes an aggregate of 486,282 shares owned beneficially by the other
reporting persons indicated in this Schedule 13D, as to which this
reporting person disclaims beneficial ownership. See Exhibit A hereto.
---------
<PAGE>
SCHEDULE 13D
- ------------------------------------------------------------------------------
CUSIP NO. 150934107 PAGE 4 OF 19 PAGES
- ------------------------------------------------------------------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 THE PHOENIX PARTNERS IIIB
LIMITED PARTNERSHIP
SEE ITEM 2 FOR IDENTIFICATION OF GENERAL PARTNERS
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [X]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
WC
- ------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM
S 2(d) OR 2(e)[_]
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
WASHINGTON
- ------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF 161,282(A)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
0(A)
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING 161,282(A)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
0(A)
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
161,282(A)
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
12 (SEE INSTRUCTIONS)
[X]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
1.04%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
14
PN
- ------------------------------------------------------------------------------
(A) Excludes an aggregate of 525,677 shares owned beneficially by the other
reporting persons indicated in this Schedule 13D, as to which this
reporting person disclaims beneficial ownership. See Exhibit A hereto.
---------
<PAGE>
SCHEDULE 13D
- ------------------------------------------------------------------------------
CUSIP NO. 150934107 PAGE 5 OF 19 PAGES
- ------------------------------------------------------------------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 PHOENIX MANAGEMENT PARTNERS III, A WASHINGTON PARTNERSHIP
SEE ITEM 2 FOR IDENTIFICATION OF GENERAL PARTNERS
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [X]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
WC
- ------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM
S 2(d) OR 2(e)[_]
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
WASHINGTON
- ------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF 161,282(A)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
0(A)
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING 161,282(A)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
0(A)
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
161,282(A)
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
12 (SEE INSTRUCTIONS)
[X]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
1.04%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
14
PN
- ------------------------------------------------------------------------------
(A) Excludes an aggregate of 525,677 shares owned beneficially by the other
reporting persons indicated in this Schedule 13D, as to which this
reporting person disclaims beneficial ownership. See Exhibit A hereto.
---------
<PAGE>
SCHEDULE 13D
- ------------------------------------------------------------------------------
CUSIP NO. 150934107 PAGE 6 OF 19 PAGES
- ------------------------------------------------------------------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 THE PHOENIX PARTNERS IV LIMITED PARTNERSHIP
SEE ITEM 2 FOR IDENTIFICATION OF GENERAL PARTNER
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [X]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
WC
- ------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM
S 2(d) OR 2(e)[_]
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
DELAWARE
- ------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF 325,000(A)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
0(A)
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING 325,000(A)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
0(A)
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
325,000(A)
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
12 (SEE INSTRUCTIONS)
[X]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
2.09%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
14
PN
- ------------------------------------------------------------------------------
(A) Excludes an aggregate of 361,959 shares owned beneficially by the other
reporting persons indicated in this Schedule 13D, as to which this
reporting person disclaims beneficial ownership. See Exhibit A hereto.
---------
<PAGE>
SCHEDULE 13D
- ------------------------------------------------------------------------------
CUSIP NO. 150934107 PAGE 7 OF 19 PAGES
- ------------------------------------------------------------------------------
- ------------------------------------------------------------------------------
NAME OF REPORTING PERSON
1 PHOENIX MANAGEMENT IV, L.L.C.
SEE ITEM 2 FOR LIST OF MEMBERS OF GENERAL PARTNER
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
2 (a) [_]
(b) [X]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
WC
- ------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM
S 2(d) OR 2(e)[_]
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
DELAWARE
- ------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF 325,000(A)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
0(A)
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING 325,000(A)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
0(A)
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
325,000(A)
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
12 (SEE INSTRUCTIONS)
[X]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
2.09%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
14
OO
- ------------------------------------------------------------------------------
(A) Excludes an aggregate of 361,959 shares owned beneficially by the other
reporting persons indicated in this Schedule 13D, as to which this
reporting person disclaims beneficial ownership. See Exhibit A hereto.
---------
<PAGE>
SCHEDULE 13D
- ------------------------------------------------------------------------------
CUSIP NO. 150934107 PAGE 8 OF 19 PAGES
- ------------------------------------------------------------------------------
ITEM 1.
SECURITY AND ISSUER.
-------------------
The title of the class of securities to which this Schedule 13D relates is
Common Stock, no par value per share (the "Common Stock"), of Cell
Therapeutics, Inc., a Washington corporation (the "Issuer"). The principal
executive offices of the Issuer are located at 201 Elliott Ave. W, Suite
400, Seattle, WA 98119.
ITEM 2.
IDENTITY AND BACKGROUND.
-----------------------
Set forth below is the following information with respect to each of the
persons filing this Schedule 13D and each of its general partners, trustees
or members, as the case may be: (a) name; (b) address of principal offices
(if entity) or residence or business address (if individual); (c) principal
business (if entity) or principal occupation and name, business and address
of employer (if individual); (d) information concerning criminal
convictions during the past five years; (e) information concerning civil or
administrative proceedings during the last five years with respect to any
state or federal securities laws and (f) state of organization or
citizenship.
I.
a) The Phoenix Partners III Liquidating Trust. The Trustee of "Phoenix III"
is Stuart C. Johnston
b) 1000 Second Avenue, Suite 3600, Seattle, WA 98104
c) Phoenix III is a Liquidating Trust for a limited partnership investment
fund.
d) No convictions in criminal proceedings(1)
e) No civil or administrative proceedings(1)
f) Washington
II.
a) Stuart C. Johnston
b) 1000 Second Avenue, Suite 3600, Seattle, WA 98104
c) Stuart C. Johnston is an Investment Fund Manager.
d) No convictions in criminal proceedings(1)
e) No civil or administrative proceedings(1)
f) U.S.A.
III.
a) The Phoenix Partners IIIB Limited Partnership, a Washington limited
partnership ("Phoenix IIIB"). The General Partner of Phoenix IIIB is:
Phoenix Management Partners III, a Washington limited partnership.
("Phoenix Management III").
b) 1000 Second Avenue, Suite 3600, Seattle, WA 98104
c) Phoenix IIIB is a Limited Partnership Investment Fund.
d) No convictions in criminal proceedings(1)
e) No civil or administrative proceedings(1)
f) Washington
<PAGE>
SCHEDULE 13D
- ------------------------------------------------------------------------------
CUSIP NO. 150934107 PAGE 9 OF 19 PAGES
- ------------------------------------------------------------------------------
IV.
a) Phoenix Management Partners III, a Washington limited partnership ("Phoenix
Management III"). The Managing General Partner of Phoenix Management III
is: Stuart C. Johnston. The Non-Managing General Partner of Phoenix
Management III is: David B. Johnston.
b) 1000 Second Avenue, Suite 3600, Seattle, WA 98104.
c) Phoenix Management III is a Limited Partnership Investment Fund Manager.
d) No convictions in criminal proceedings(1)
e) No civil or administrative proceedings(1)
f) Washington
V.
a) The Phoenix Partners IV Limited Partnership, a Delaware limited
partnership("Phoenix IV"). The General Partner of Phoenix IV is Phoenix
Management IV, L.L.C., a Delaware limited liability company ("Phoenix
Management IV").
b) 1000 Second Avenue, Suite 3600, Seattle, WA 98104.
c) Phoenix IV is a Limited Partnership Investment Fund.
d) No convictions in criminal proceedings(1)
e) No civil or administrative proceedings(1)
f) Delaware
VI.
a) Phoenix Management IV, L.L.C., a Delaware limited liability company
("Phoenix Management IV"). The Managing Member of Phoenix Management IV is:
Stuart C. Johnston. The Non-Managing Member of Phoenix Management IV is:
David B. Johnston.
b) 1000 Second Avenue, Suite 3600, Seattle, WA 98104.
c) Phoenix Management IV is a Limited Liability Company Investment Fund
Manager.
d) No convictions in criminal proceedings(1)
e) No civil or administrative proceedings(1)
f) Delaware.
- ------------------------
Footnotes to Item 2:
- -------------------
(1) During the last five years, no person listed above has been convicted in a
criminal proceeding (excluding traffic violations or similar misdemeanors), nor
has any such person been a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction that resulted in such person
becoming subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to, federal or
state securities laws or finding any violation with respect to such laws.
ITEM 3.
SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
-------------------------------------------------
The shares of the Issuer's Common Stock with respect to which this Schedule
13D is being filed were purchased by the reporting persons using general
investment funds contributed by their respective partners or members. Set
forth in Exhibit B hereto is a list of the acquisitions, giving the
---------
purchase price thereof. Such information is incorporated by reference
herein.
<PAGE>
SCHEDULE 13D
- ------------------------------------------------------------------------------
CUSIP NO. 150934107 PAGE 10 OF 19 PAGES
- ------------------------------------------------------------------------------
ITEM 4.
PURPOSE OF TRANSACTION.
----------------------
The acquisition of the shares of the Issuer's Common Stock that are the
subject of this filing was made for the purpose of investment and not with
a view to distribution of the shares or with a view toward acquiring
control of the Issuer. The reporting persons may sell all or part of such
shares or acquire additional securities of the Issuer depending on market
conditions and other economic factors.
Except as described above, no reporting person has any plans or proposals
that relate to or would result in:
a. The acquisition by any person of additional securities of the Issuer,
or the disposition of securities of the Issuer;
b. An extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving the Issuer or any of its
subsidiaries;
c. A sale or transfer of a material amount of assets of the Issuer or any
of its subsidiaries;
d. Any change in the present board of directors or management of the
Issuer, including any plans or proposals to change the number or term
of directors or to fill any existing vacancies on the board;
e. Any material change in the present capitalization or dividend policy
of the Issuer;
f. Any other material change in the Issuer's business or corporate
structure;
g. Changes in the Issuer's charter, bylaws or instruments corresponding
thereto or other actions that may impede the acquisition of control of
the Issuer by any person;
h. Causing a class of securities of the Issuer to be delisted from a
national securities exchange or to cease to be authorized to be quoted
in an inter-dealer quotation system of a registered national
securities association;
i. A class of equity securities of the Issuer becoming eligible for
termination of registration pursuant to Section 12(g)(4) of the
Exchange Act; or
j. Any action similar to any of those enumerated above.
ITEM 5.
INTEREST IN SECURITIES OF THE ISSUER.
------------------------------------
(A) AND (B) With respect to the amount of Common Stock beneficially owned
by each reporting person, the nature of such beneficial ownership and the
related percentages of the class of Common Stock, the information contained
in each of the cover pages and in Exhibit A hereto is incorporated by
----------
reference herein. As indicated in the cover pages hereto , pursuant to Rule
13d-4 each of the reporting persons hereby expressly disclaims beneficial
ownership with respect to any and all shares beneficially owned by the
other reporting persons indicated in this Schedule 13D. The aggregate
number
<PAGE>
SCHEDULE 13D
- ------------------------------------------------------------------------------
CUSIP NO. 150934107 PAGE 11 OF 19 PAGES
- ------------------------------------------------------------------------------
and percentage of the class of securities identified pursuant to Item 1 of
this Schedule 13D that are beneficially owned by the persons listed in Item 2
are as follows:
<TABLE>
<CAPTION>
Entity Shares Beneficially Owned Percent of Class(1)
------ ------------------------- -------------------
<S> <C> <C>
Phoenix III 200,677 (2) 1.29%
Stuart C. Johnston 200,677 (2) 1.29%
Phoenix IIIB 161,282 (3) 1.04%
Phoenix Management III 161,282 (3) 1.04%
Phoenix IV 325,000 (4) 2.09%
Phoenix Management IV 325,000 (4) 2.09%
------- ----
TOTAL 686,959 4.42%
</TABLE>
_________________
(1) All percentages in this table are based, pursuant to Rule 13d-1(e)
promulgated under the Securities Exchange Act of 1934, on 15,567,959
shares of the Common Stock of the Company outstanding, as reported in
the Company's Quarterly Report on Form 10-Q for the period ended September
30, 1999.
(2) These shares are held of record by Phoenix III, which has sole voting and
investment power with respect to such shares. Stuart C. Johnston, as the
Trustee of Phoenix III, may be deemed to also have sole voting and
investment power with respect to such shares.
(3) These shares are held of record by Phoenix IIIB which has sole voting and
investment power with respect to such shares. Phoenix Management III, as
the General Partner of Phoenix III, may be deemed to also have sole voting
and investment power with respect to such shares. The Managing and Non-
Managing General Partners of the general partner of Phoenix III may be
deemed to have shared voting and dispositive power over the 161,282 shares
held of record by Phoenix IIIB.
(4) These shares are held of record by Phoenix IV, which has sole voting and
investment power with respect to such shares. Phoenix Management IV, as
the General Partner of Phoenix IV, may be deemed to also have sole voting
and investment power with respect to such shares. The Managing and Non-
Managing Members of the General Partner of Phoenix IV may be deemed to
have shared voting and dispositive power over the 325,000 shares held of
record by Phoenix IV.
(C) The following is a list of transactions in the Issuer's securities by the
filing parties within the last 60 days:
<TABLE>
<CAPTION>
Entity Date Shares Transaction
------ ----- ------ -----------
<S> <C> <C> <C>
The Phoenix Partners II
Liquidating Trust 12/23/99 190,133 Distribution to beneficiaries
without consideration
</TABLE>
<PAGE>
SCHEDULE 13D
- ------------------------------------------------------------------------------
CUSIP NO. 150934107 PAGE 12 OF 19 PAGES
- ------------------------------------------------------------------------------
ITEM 6.
CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
------------------------------------------------------------------------
SECURITIES OF THE ISSUER.
-------------------------
Under the terms of the Limited Partnership Agreements for Phoenix IIIB and
Phoenix IV and the Liquidating Trust Agreement for Phoenix III (the
"Funds"), the respective general partners and trustee of such Funds possess
the power to manage the investment activities of the Funds, including the
power to vote and direct the disposition of the securities with respect to
which this Schedule 13D is filed.
ITEM 7.
MATERIAL TO BE FILED AS EXHIBITS.
--------------------------------
The following exhibits are attached hereto:
A - Beneficial Ownership of Each Reporting Person
B - List of Acquisitions of Common Stock by Each Reporting Person
C - Statement Appointing Designated Filer and Authorized Signer
<PAGE>
SCHEDULE 13D
- ------------------------------------------------------------------------------
CUSIP NO. 150934107 PAGE 13 OF 19 PAGES
- ------------------------------------------------------------------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: DECEMBER 27, 1999
The Phoenix Partners III Liquidating Trust
By: /s/ Stuart C. Johnston
-----------------------------------
Name: Stuart C. Johnston
Title: Trustee
Stuart C. Johnston
By: /s/ Stuart C. Johnston
-----------------------------------
Name: Stuart C. Johnston
The Phoenix Partners IIIB Limited Partnership
By: Phoenix Management Partners III,
a Washington limited partnership
By: /s/ Stuart C. Johnston
-----------------------------------
Name: Stuart C. Johnston
Title: Managing General Partner
Phoenix Management Partners III,
a Washington limited partnership
By: /s/ Stuart C. Johnston
-----------------------------------
Name: Stuart C. Johnston
Title: Managing General Partner
<PAGE>
SCHEDULE 13D
- ------------------------------------------------------------------------------
CUSIP NO. 150934107 PAGE 14 OF 19 PAGES
- ------------------------------------------------------------------------------
The Phoenix Partners IV Limited Partnership
By: Phoenix Management IV, L.L.C.
By: /s/ Stuart C. Johnston
---------------------------------------
Name: Stuart C. Johnston
Title: Managing Member
Phoenix Management IV, L.L.C.
By: /s/ Stuart C. Johnston
----------------------------------------
Name: Stuart C. Johnston
Title: Managing Member
<PAGE>
SCHEDULE 13D
- ------------------------------------------------------------------------------
CUSIP NO. 150934107 PAGE 15 OF 19 PAGES
- ------------------------------------------------------------------------------
EXHIBIT A
---------
BENEFICIAL OWNERSHIP OF EACH REPORTING PERSON
---------------------------------------------
<TABLE>
<CAPTION>
Name of Reporting Person Number of Shares Percent of Class(1)
------------------------ ----------------- -------------------
<S> <C> <C>
Phoenix III 200,677 1.29
Stuart C. Johnston 200,677 (2) 1.29
Phoenix IIIB 161,282 1.04
Phoenix Management III 161,282 (3) 1.04
Phoenix IV 325,000 2.09
Phoenix Management IV 325,000 (4) 2.09
___________ _______________
TOTAL 686,949 4.42%
</TABLE>
(1) The respective percentages set forth in this column were obtained by
dividing the number of shares in the second column by the aggregate number
of outstanding shares of Common Stock, which aggregate amount, according to
the cover page of the Issuer's Quarterly Report on Form 10-Q for the
period ended September 30, 1999, was 15,567,959
(2) Represents shares held of record by Phoenix III, of which Stuart C. Johnston
is the Trustee.
(3) Represents shares held of record by Phoenix IIIB, of which Phoenix
Management III is the general partner.
(4) Represents shares held of record by Phoenix IV, of which Phoenix Management
IV is the general partner.
<PAGE>
SCHEDULE 13D
- ------------------------------------------------------------------------------
CUSIP NO. 150934107 PAGE 16 OF 19 PAGES
- ------------------------------------------------------------------------------
EXHIBIT B
---------
LIST OF ACQUISITIONS OF ISSUER'S SECURITIES BY EACH REPORTING PERSON
--------------------------------------------------------------------
<TABLE>
<CAPTION>
Number of Price per
Name of Reporting Person Date of Purchase Class of Securities Shares(1) Share(1)
------------------------ ---------------- ------------------- ---------- --------
<S> <C> <C> <C> <C>
Phoenix III 8-11-92 Common Stock 15,841 $17.50
Phoenix III 11-13-92 Common Stock 15,841 $17.50
Phoenix III 3-21-95 Series A Preferred 24,575 $11.28
Phoenix III 6-16-95 Series A Preferred 49,012 $11.28
Phoenix III 9-24-96 Series A Preferred 24,575 $11.28
Phoenix III JAN-MAR 98 Common Stock 70,833 $15.30
Phoenix IIIB 8-11-92 Common Stock 12,730 $17.50
Phoenix IIIB 11-13-92 Common Stock 12,731 $17.50
Phoenix IIIB 3-21-95 Series A Preferred 19,751 $11.28
Phoenix IIIB 6-16-95 Series A Preferred 39,652 $11.28
Phoenix IIIB 9-24-96 Series A Preferred 19,751 $11.28
Phoenix IIIB JAN-MAR 98 Common Stock 56,667 $15.30
Phoenix IV 3-21-97 Common Stock 300,000 $10.00
Phoenix IV 10-27-97 Common Stock 25,000 $16.00
</TABLE>
________________
(1) Expressed on a common equivalent share basis. All outstanding shares of
Series A Preferred Stock of the Issuer were automatically converted into Common
Stock in connection with the Issuer's initial public offering of its Common
Stock on March 21, 1997.
<PAGE>
SCHEDULE 13D
- ------------------------------------------------------------------------------
CUSIP NO. 150934107 PAGE 17 OF 19 PAGES
- ------------------------------------------------------------------------------
EXHIBIT C
---------
STATEMENT APPOINTING DESIGNATED FILER AND AUTHORIZED SIGNER
The undersigned entities (the "Reporting Persons") hereby designate PHOENIX
MANAGEMENT IV (the "Designated Filer") as the beneficial owner to make filings
of Schedules 13D and 13G (and any amendments thereto) pursuant to Section 13(d)
of the Securities Exchange Act of 1934 (the "Exchange Act") and of Forms 3, 4
and 5 pursuant to Section 16(a) of the Exchange Act (collectively, the
"Reports") with respect to the securities of Cell Therapeutics, Inc. (the
"Company").
Each Reporting Person hereby further authorizes and designates STUART C.
JOHNSTON (the "Authorized Signer") to execute and file on behalf of such
Reporting Person the Reports with respect to the securities of the Company,
including all Schedules 13D and 13G and Forms 3, 4 and 5, and any amendments
thereto, that the Reporting Person may be required to file with the United
States Securities and Exchange Commission as a result of the Reporting Person's
ownership of, or transactions in, securities of the Company.
The authority of the Designated Filer and the Authorized Signer under this
document with respect to each Reporting Person shall continue until such
Reporting Person is no longer required to file Forms 3, 4 and 5 or Schedules 13D
or 13G with respect to the Reporting Person's ownership of, or transactions in,
securities of the Company, unless earlier revoked in writing. Each Reporting
Person acknowledges that the Designated Filer and the Authorized Signer are not
assuming any of the Reporting Person's responsibilities to comply with Section
13(d) or Section 16 of the Exchange Act.
17
<PAGE>
SCHEDULE 13D
- ------------------------------------------------------------------------------
CUSIP NO. 150934107 PAGE 18 OF 19 PAGES
- ------------------------------------------------------------------------------
SIGNATURE
Dated: December 27, 1999
The Phoenix Partners III Liquidating Trust
By: /s/ Stuart C. Johnston
-----------------------------------
Name: Stuart C. Johnston
Title: Trustee
Stuart C. Johnston
By: /s/ Stuart C. Johnston
-----------------------------------
Name: Stuart C. Johnston
The Phoenix Partners IIIB Limited Partnership
By: Phoenix Management Partners III,
a Washington limited partnership
By: /s/ Stuart C. Johnston
------------------------------------
Name: Stuart C. Johnston
Title: Managing General Partner
Phoenix Management Partners III,
a Washington limited partnership
By: /s/ Stuart C. Johnston
-------------------------------------
Name: Stuart C. Johnston
Title: Managing General Partner
<PAGE>
SCHEDULE 13D
- ------------------------------------------------------------------------------
CUSIP NO. 150934107 PAGE 19 OF 19 PAGES
- ------------------------------------------------------------------------------
The Phoenix Partners IV Limited Partnership
By: Phoenix Management IV, L.L.C.
By: /s/ Stuart C. Johnston
---------------------------------------
Name: Stuart C. Johnston
Title: Managing Member
Phoenix Management IV, L.L.C.
By: /s/ Stuart C. Johnston
----------------------------------------
Name: Stuart C. Johnston
Title: Managing Member
